Stock Price Quote

SHALBY LTD.

NSE : SHALBYBSE : 540797ISIN CODE : INE597J01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE297.401.25 (+0.42 %)
PREV CLOSE ( ) 296.15
OPEN PRICE ( ) 298.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18309
TODAY'S LOW / HIGH ( )293.50 299.80
52 WK LOW / HIGH ( )114.35 333.85
NSE295.10-1 (-0.34 %)
PREV CLOSE( ) 296.10
OPEN PRICE ( ) 298.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99506
TODAY'S LOW / HIGH( ) 293.25 300.00
52 WK LOW / HIGH ( )115 339.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-08 2004
Management Info
Vikram Shah - Chairman Vikram Shah - Managing Director
Registered Office

Address Shalby Multi- Specialty Hospitals,Opp. Karnavati Club,S. G. Highway,
Ahmedabad,
Gujarat-380015

Phone 079-40203000

Email companysecretary@shalby.in

Website www.shalby.org

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

07Feb Shalby submits intimation of grant of
In accordance with the provisions of the Regulation 30 of the Securities..
19Jan Zydus Lifesciences, Lupin and Indoco R
Zydus Lifesciences’ wholly owned subsidiary -- Zydus Worldwide DMCC, has..
19Jan Shalby gains on acquiring majority sta
Shalby is currently trading at Rs. 309.45, up by 5.25 points or 1.73% fr..
18Jan Shalby acquires majority stake in Sana
Shalby has made a strategic investment in Sanar International hospitals..
12Jan UltraTech Cement, TARC and Thomas Cook
UltraTech Cement has entered into Share Subscription and Shareholders Ag..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit247.24808.079999999999
Gross Profit 384.79 1213.56
Operating Profit 484.21615.2
Net Sales 1951.537080.17

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE)
peergroup  4195.00 (5.17%)
M.Cap ( in Cr)4590.28
Jupiter Life Line (BSE)
peergroup  1525.95 (6.06%)
M.Cap ( in Cr)10005.05
Krishna Inst.Medi (BSE)
peergroup  2237.60 (1.12%)
M.Cap ( in Cr)17907.02
Yatharth Hospital (BSE)
peergroup  477.20 (3.47%)
M.Cap ( in Cr)4096.77
Narayana Hrudayalay (BSE)
peergroup  1382.25 (0.84%)
M.Cap ( in Cr)28247.77

Shareholding Pattern

PROMOTERS 74.12%
NON-INSTITUTION 21.26%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Shalby Ltd.

Shalby Ltd. was incorporated in the year 2004. Its today's share price is 297.4. Its current market capitalisation stands at Rs 3212.21 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7080.17 Cr and Total Income of Rs.7273.82 Cr. The company's management includes Tushar Shah, Vijay Kedia, Sujana Shah, Tej Malhotra, Umesh Menon, Ashok Bhatia, Shyamal Joshi, Vikram Shah, Vikram Shah.

It is listed on the BSE with a BSE Code of 540797 , NSE with an NSE Symbol of SHALBY and ISIN of INE597J01018. It's Registered office is at Shalby Multi- Specialty Hospitals,Opp. Karnavati Club,S. G. HighwayAhmedabad-380015, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are GK Choksi & Co, TR Chadha & Co, TR Chadha & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.